Personalis, Inc. · 1 day ago
Medical Science Liaison – Oncology (Field-Based Genomics/MRD Specialist) - East
United States
Full-time
Remote
Entry, Mid Level
1+ years expPersonalis is transforming cancer management through personalized testing and genomic profiling. The Medical Science Liaison (MSL) – Oncology engages healthcare professionals to support the oncology genomics portfolio, focusing on the NeXT Personal ctDNA assay while also providing broader scientific support across the product line.
BiotechnologyGeneticsHealth CareHealth Diagnostics
Responsibilities
Deliver clinical and scientific presentations on data supporting Personalis’ oncology products – with special emphasis on the NeXT Personal MRD assay – to healthcare providers, academic groups, and other stakeholders
Establish and maintain strong collaborative relationships with key opinion leaders (KOLs) and leading physicians in the oncology community
Engage academic and community KOLs through regular scientific exchange to promote understanding and adoption of our novel ctDNA and genomic technologies
Identify opportunities to involve KOLs in advisory boards, speaker programs, or research collaborations that enhance the visibility of Personalis’ assays
Represent Personalis at scientific and clinical conferences, symposia, and other educational events
This includes supporting PIs with clinical study data or posters, participating in panel discussions, and hosting educational workshops or grand rounds to highlight the clinical evidence and best practices for using our ctDNA assay and broader test portfolio
Ensure consistent and medically accurate messaging in all external engagements
Travel frequently (approximately 50% of the time) to execute the above field responsibilities
This includes local and overnight travel for HCP meetings, conference attendance, internal training sessions, and other field engagements
Support and coordinate clinical research and evidence-generation initiatives involving Personalis’ tests
Identify and liaise with potential clinical trial sites and investigators for company-sponsored studies or investigator-initiated trials, particularly those evaluating MRD with NeXT Personal
Facilitate collaboration with researchers by providing scientific expertise, assisting in study site onboarding, and monitoring study progress in accordance with appropriate guidelines
Contribute medical and scientific expertise to the development and review of content such as slide decks, white papers, training modules, and publications to ensure accuracy and alignment with current data
Critically appraise new research findings and incorporate them into educational materials and talking points, working closely with Marketing and Medical Affairs on messaging that meets both scientific and compliance standards
Continuously gather insights from the field and stay abreast of emerging research in oncology and molecular diagnostics
Monitor new studies, competitive developments, and clinical guidelines related to MRD, ctDNA, and precision oncology
Share relevant scientific updates and field feedback with internal teams (Medical Affairs, R&D, Marketing) to inform strategy, product development, and data needs
Qualification
Required
Advanced degree in a relevant scientific or clinical discipline (PhD, PharmD, MD or equivalent) strongly preferred; at minimum, a Master's degree in life sciences, genetics, molecular biology or related field is required
Candidates with a Genetic Counseling certification (CGC/MS) or other advanced clinical training and significant oncology genomics experience will also be considered
In-depth knowledge of oncology and molecular biology is essential, including familiarity with cancer genomics, biomarkers, and the principles of liquid biopsy testing
Experience or training in ctDNA assays, next-generation sequencing, or minimal residual disease monitoring is highly desirable
1+ years of experience in oncology or precision medicine, whether in clinical practice, research, or industry, is preferred
Prior experience in a field medical affairs role (MSL or similar) is a plus but not strictly required
Excellent oral and written communication skills, with the ability to interpret and present complex scientific data in a clear, concise manner
Demonstrated ability to build and sustain professional relationships with healthcare providers, researchers, and cross-functional team members
Self-motivated and able to work effectively in an independent, remote field-based setting, while maintaining close collaboration with a broader team
Excellent organizational and time-management skills to manage a territory or set of accounts, plan travel, and handle multiple projects simultaneously
Willingness and ability to travel up to ~50%, including overnight trips, by car and air, as needed for territory coverage and meetings
Preferred
Experience in a field medical affairs role (MSL or similar) is a plus but not strictly required
Strong technical writing skills are beneficial for contributing to scientific materials
Exceptional candidates with strong oncology expertise and communication skills may qualify without direct MSL experience, especially if they have worked on clinical studies or educational programs in relevant areas
Benefits
Medical
Dental
Vision
401(k) match
ESPP
Tuition reimbursement
Sick/vacation time
Commuter benefits/ EV charging stations
Onsite gym
Wellness benefits
Company
Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing.
201-500 employees
H1B Sponsorship
Personalis, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (10)
2023 (17)
2022 (19)
2021 (12)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$311.25MKey Investors
MerckTempusLightspeed Venture Partners
2024-12-19Post Ipo Equity· $50M
2024-08-16Post Ipo Equity· $36.15M
2021-01-27Post Ipo Equity· $150.1M
Leadership Team
Aaron Tachibana
Chief Financial Officer
Christian Haudenschild
Senior Vice President
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase